Heartflow, Inc.

HTFL Healthcare Health Information Services

Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.

Revenue
+47.6%
EPS
+87.7%
Free cash flow
+62.6%

Quarter to June 2026, against a year earlier

51.74 0.21 −0.40%
Market cap
$4.5B
P/E
0.0×
Fwd P/E
−72.9×
Dividend yield
—
F-score
5/9
Altman Z
7.22
Beneish M
−2.55
Dividend safety
n/a

Heartflow, Inc. (HTFL) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Heartflow, Inc. (HTFL) trades at a P/S ratio of 21.3×. Over the past ten years it has ranged from 1.2× (August 2025) to 24.7× (October 2026); the current reading is higher than 96% of that period. That is above the Health Information Services industry median of 1.8× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 6.1× 399.20%
FY2024 1.2× 0.00%
FY2023 1.2× —

Quarterly newest first

Period P/S ratio Change
Jun 2026 12.0× 9.81%
Mar 2026 10.9× 78.37%
Dec 2025 6.1× (40.23%)
Sep 2025 10.2× 735.23%
6 more quarters

Against its own ten years

Low 1.2× High 24.7×
Ten-year median 10.6×
Current reading's percentile 96

P/S ratio against peers

Company P/S ratio
TDOC Teladoc Health, Inc. compare 0.7×
PRVA Privia Health Group, Inc. compare 1.2×
OMCL Omnicell, Inc. compare 1.4×
WAY Waystar Holding Corp. compare 4.4×
HQY HealthEquity, Inc. compare 6.3×
SDGR Schrodinger, Inc. compare 8.1×
DOCS Doximity, Inc. compare 9.0×
HNGE Hinge Health Inc. compare 12.7×
HTFL Heartflow, Inc. 21.3×
Health Information Services industry median 1.8×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on HTFL